City of Hope
Institute for Follicular Lymphoma Innovation Invests $11M in PeproMene Bio's CAR T-Cell Therapy
The firm is developing the BAFF-R-targeted therapy PMB-CT01 for treating B-cell malignancies, including heavily pretreated follicular lymphoma.
In Brief This Week: Atsena, Papillon, City of Hope, Labcorp, Quest Diagnostics, Angle
News items for the week of Sept. 16, 2024.
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.
Tumor-derived and cell-free microRNAs showed high sensitivity and specificity for pancreatic cancer detection when combined with a CA 19-9 blood test.
AccessHope Real-World Data Study Identifies Molecular Testing Gaps in Pancreatic Cancer Care
Premium
Out of around 100 cases reviewed by subspecialists, most completed recommended, guideline-concordant germline and somatic testing, but many still did not.
Feb 22, 2022
Oct 8, 2021